-+ 0.00%
-+ 0.00%
-+ 0.00%

BeyondSpring Reports Plinabulin Plus Docetaxel Boosts Survival in Asian EGFR Wild-Type NSCLC Phase 3 Trial

路透·12/12/2025 12:00:56

登錄查看新聞詳情